Evidence map›Paper›PMID 36387996›Full record

ArticleFrontiers in neuroanatomy2022

Cannabinoid CB

Andrea Manterola, Juan Carlos Chara, Tania Aguado, Javier Palazuelos, Carlos Matute, Susana Mato

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neuroanatomy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Cannabinoid CBCell communication and signaling : CCS · 2026
    Article
  3. Genetic Tools in Rodents to Study Cannabinoid Functions.Current topics in behavioral neurosciences · 2026
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 1 country.

Andrea ManterolaDepartment of Neurosciences, University of the Basque Country UPV/EHU, Leioa, Spain.
Juan Carlos CharaDepartment of Neurosciences, University of the Basque Country UPV/EHU, Leioa, Spain.
Tania AguadoCentro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.
Javier PalazuelosCentro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.
Carlos MatuteDepartment of Neurosciences, University of the Basque Country UPV/EHU, Leioa, Spain.
Susana MatoDepartment of Neurosciences, University of the Basque Country UPV/EHU, Leioa, Spain.
University of the Basque Country · ESAchucarro Basque Center for Neuroscience · ESBiomedical Research Networking Center on Neurodegenerative Diseases · ESInstituto Ramón y Cajal de Investigación Sanitaria · ESUniversidad Complutense de Madrid · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adult oligodendrocyte progenitor cells (OPCs) give rise to myelinating oligodendrocytes through life and play crucial roles in brain homeostasis and plasticity during health and disease. Cannabinoid compounds acting through CB

Indexed as

cannabinoid CB1 receptorhippocampusimmunoelectron microscopyNG2-EYFP reporter miceNG2 gliaoligodendrocyte progenitor cell (OPC)

Identifiers

PMID36387996
PMCPMC9650068
OpenAlexW4307702367

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.